Who
Ronen Tchelet
VP of Research and Bus. Dvlpmt
Company insider
Files Form 4 as: VP of Research and Bus. Dvlpmt, Dyadic International.
In numbers
- Trades disclosed
- 90
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $630K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Jun 2019
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —18,064 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —47,250 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —47,250 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —18,064 at $0.00 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —8,980 at $0.00 | filing |
| 13 Mar 2024filed 15 Apr 2024 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | —11,169 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code A | $18K12,684 at $1.38 | filing |
| 8 Jul 2022filed 11 Jul 2022 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —1,089 at $0.00 | filing |
| 8 Jul 2022filed 11 Jul 2022 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code M | $1,7101,089 at $1.57 | filing |
| 8 Jul 2022filed 11 Jul 2022 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $3,7131,089 at $3.41 | filing |
| 7 Jul 2022filed 11 Jul 2022 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —7,854 at $0.00 | filing |
| 7 Jul 2022filed 11 Jul 2022 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code M | $12K7,854 at $1.57 | filing |
| 7 Jul 2022filed 11 Jul 2022 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Sold | $27K7,854 at $3.50 | filing |
| 3 Jan 2022filed 5 Jan 2022 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 4 Jan 2021filed 6 Jan 2021 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —67,500 at $0.00 | filing |
| 2 Jan 2020filed 3 Jan 2020 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 11 Dec 2019filed 12 Dec 2019 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —4,575 at $0.00 | filing |
News
Lisata Therapeutics (NASDAQ:LSTA) versus Dyadic International (NASDAQ:DYAI) Head to Head ContrastDYAI · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Ronen Tchelet; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.